297 related articles for article (PubMed ID: 17845390)
1. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Fujimori K; Sato T; Satomi S
Ther Apher Dial; 2007 Oct; 11(5):319-24. PubMed ID: 17845390
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
[TBL] [Abstract][Full Text] [Related]
3. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
4. Adult ABO-incompatible liver transplantation, using A and B donors.
Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
[TBL] [Abstract][Full Text] [Related]
5. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
6. Antibody elimination by apheresis in living donor liver transplant recipients.
Kawagishi N; Ohkohchi N; Fujimori K; Orii T; Koyamada N; Kikuchi H; Sekiguchi S; Tsukamoto S; Sato T; Satomi S
Ther Apher; 2001 Dec; 5(6):449-54. PubMed ID: 11800079
[TBL] [Abstract][Full Text] [Related]
7. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
8. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of ABO-incompatible living-donor liver transplantation: a single-center experience.
Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
J Hepatobiliary Pancreat Surg; 2009; 16(4):468-72. PubMed ID: 19333538
[TBL] [Abstract][Full Text] [Related]
10. Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study.
Sanada Y; Mizuta K; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Koinuma T; Koyama K; Tanaka S; Misawa K; Wada M; Nunomiya S; Yasuda Y; Kawarasaki H
Ther Apher Dial; 2012 Aug; 16(4):368-75. PubMed ID: 22817126
[TBL] [Abstract][Full Text] [Related]
11. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
[TBL] [Abstract][Full Text] [Related]
12. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
[TBL] [Abstract][Full Text] [Related]
13. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
[TBL] [Abstract][Full Text] [Related]
14. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation.
Haga H; Egawa H; Shirase T; Miyagawa A; Sakurai T; Minamiguchi S; Yamabe H; Manabe T; Tanaka K
Liver Transpl; 2004 Jan; 10(1):16-27. PubMed ID: 14755773
[TBL] [Abstract][Full Text] [Related]
15. Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis.
Ishikawa A; Itoh M; Ushlyama T; Suzuki K; Fujita K
Clin Transplant; 1998 Apr; 12(2):80-3. PubMed ID: 9575393
[TBL] [Abstract][Full Text] [Related]
16. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.
Egawa H; Oike F; Buhler L; Shapiro AM; Minamiguchi S; Haga H; Uryuhara K; Kiuchi T; Kaihara S; Tanaka K
Transplantation; 2004 Feb; 77(3):403-11. PubMed ID: 14966415
[TBL] [Abstract][Full Text] [Related]
17. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
[TBL] [Abstract][Full Text] [Related]
18. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody.
Boberg KM; Foss A; Midtvedt K; Schrumpf E
Clin Transplant; 2006; 20(2):265-8. PubMed ID: 16640538
[TBL] [Abstract][Full Text] [Related]
19. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the humoral immune response in two paediatric patients transplanted with split livers from ABO-incompatible living-related donors: appearance of cytomegalovirus-induced ABO antibodies.
Rydberg L; Ascher H; Krantz M; Kullberg-Lindh C; Olausson M; Svalander C; Breimer ME
Transfus Med; 2005 Apr; 15(2):137-44. PubMed ID: 15859981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
